Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1558 to 1607 of 8289 in total 
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
779\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ornithine decarboxylase-like protein (ec 4.1.1.17) (odc-paralogue) (odc-p). [source:swissprot;acc:q96a70]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8379.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8729.16\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04167\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
780\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
calcineurin b subunit isoform 1 (protein phosphatase 2b regulatory subunit 1) (protein phosphatase 3 regulatory subunit b alpha isoform 1). [source:swissprot;acc:p06705]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7325.81\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7631.04\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
781\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav proto-oncogene. [source:swissprot;acc:p15498]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8109.84\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8447.62\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04165\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
782\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
putative fork head domain transcription factor afx1 (forkhead box protein o4). [source:swissprot;acc:p98177]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7538.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.74\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.33\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
783\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tweety homolog 1; tweety homolog. [source:refseq;acc:nm\_020659]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, brain isoform (ec 3.6.3.14) (v-atpase b2 subunit) (vacuolar proton pump b isoform 2) (endomembrane proton pump 58 kda subunit) (ho57). [source:swissprot;acc:p21281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.37\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1121\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
784\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoglobin (histoglobin) (hgb) (stellate cell activation-associated protein). [source:swissprot;acc:q8wwm9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit e (ec 3.6.3.14) (v-atpase e subunit) (vacuolar proton pump e subunit) (v-atpase 31 kda subunit) (p31). [source:swissprot;acc:p36543]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
5874.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.1121\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
785\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hemk protein homolog (ec 2.1.1.-) (m.hsahemkp). [source:swissprot;acc:q9y5r4]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
4997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5557.17\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hemoglobin gamma-a and gamma-g chains. [source:swissprot;acc:p02096]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.24\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
786\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid beta a4 protein precursor (app) (abpp) (alzheimer's disease amyloid protein) (cerebral vascular amyloid peptide) (cvap) (protease nexin-ii) (pn-ii) (appi) (prea4) [contains: soluble app-alpha (s-app- alpha); soluble app-beta (s-app-beta); c99; beta-amyloid protein 42 (beta-app42); beta-amyloid protein 40 (beta-app40); c83; p3(42); p3(40); gamma-ctf(59) (gamma-secretase c-terminal fragment 59) (amyloid intracellular domain 59) (aid(59)); gamma-ctf(57) (gamma- secretase c-terminal fragment 57) (amyloid intracellular domain 57) (aid(57)); gamma-ctf(50) (gamma-secretase c-terminal fragment 50) (amyloid intracellular domain 50) (aid(50)); c31]. [source:swissprot;acc:p05067]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7538.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.27\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pyruvate carboxylase, mitochondrial precursor (ec 6.4.1.1) (pyruvic carboxylase) (pcb). [source:swissprot;acc:p11498]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9304.83\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
10347.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11204\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
787\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tweety homolog 2. [source:refseq;acc:nm\_032646]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 2 (v-atpase 116-kda isoform a2) (tj6). [source:swissprot;acc:q9y487]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5890.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6547.9\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11161\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
788\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hemoglobin zeta chain (hbaz). [source:swissprot;acc:p02008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 3 (v- atpase 116-kda isoform a3) (osteoclastic proton pump 116 kda subunit) (oc-116 kda) (oc116) (t-cell immune regulator 1) (t cell immune response cdna7 protein) (tirc7). [source:swissprot;acc:q13488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5890.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6547.81\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11161\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
789\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
alpha 2 globin. [source:refseq;acc:nm\_000517]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.23\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5890.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6547.99\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1116\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
790\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
forkhead box protein o3a (forkhead in rhabdomyosarcoma-like 1) (af6q21 protein). [source:swissprot;acc:o43524]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5890.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6548.28\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.1116\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
791\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid-like protein 1 precursor (aplp) (aplp-1) [contains: c30]. [source:swissprot;acc:p51693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.25\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 3; wd-repeat protein sazd. [source:refseq;acc:nm\_006453]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
4025.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
4474.3\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11154\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
792\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
axonemal dynein light intermediate polypeptide 1 (inner dynein arm light chain, axonemal) (hp28). [source:swissprot;acc:o14645]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6772.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7526.2\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11125\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
myoglobin. [source:swissprot;acc:p02144]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.42\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.24\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
793\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
hemoglobin theta-1 chain. [source:swissprot;acc:p09105]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7538.41\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.23\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
putative n6-dna-methyltransferase (ec 2.1.1.-) (protein pred28) (m.hsahemk2p). [source:swissprot;acc:q9y5n5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5036.92\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
5596.36\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11107\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
794\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
amyloid-like protein 2 precursor (amyloid protein homolog) (apph) (cdei-box binding protein) (cdebp). [source:swissprot;acc:q06481]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7538.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7852.34\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04163\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase ii, alpha isozyme (ec 5.99.1.3). [source:swissprot;acc:p11388]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6441.17\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7154.55\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11075\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
795\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna topoisomerase ii, beta isozyme (ec 5.99.1.3). [source:swissprot;acc:q02880]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6441.14\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7154.13\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11069\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
thyroid receptor interacting protein 12 (trip12). [source:swissprot;acc:q14669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7821.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8147.14\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04159\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
796\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear receptor co-repressor/hdac3 complex subunit tblr1 (tbl1- related protein 1). [source:swissprot;acc:q9bzk7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vav-3 protein. [source:swissprot;acc:q9ukw4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8108.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8445.65\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04159\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
797\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin beta-1 subunit (karyopherin beta-1 subunit) (nuclear factor p97) (importin 90). [source:swissprot;acc:q14974]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
8383.16\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8731.6\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04156\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
798\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7893.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8221.03\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04154\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 1x protein (transducin-beta-like 1, x-linked). [source:swissprot;acc:o60907]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6834.54\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
7590.49\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.11061\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
799\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
transducin beta-like 1y protein (transducin-beta-like 1, y-linked). [source:swissprot;acc:q9bq87]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 183-like 1. [source:refseq;acc:nm\_178861]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
7543.76\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7857\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04152\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
800\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 67 kda subunit precursor (ec 2.4.1.119) (ribophorin i) (rpn-i). [source:swissprot;acc:p04843]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
7839.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8164.84\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04145\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
orphan nuclear receptor nr6a1 (germ cell nuclear factor) (gcnf) (retinoid receptor-related testis specific receptor) (rtr). [source:swissprot;acc:q15406]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6075.55\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
6746.92\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.1105\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
801\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-3 subunit (karyopherin alpha-3 subunit) (srp1-gamma). [source:swissprot;acc:o00505]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6456.35\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7169.75\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7837.99\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
8162.73\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.04143\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
802\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
target of egr1, member 1 (nuclear); target of egr1, member 1. [source:refseq;acc:nm\_025077]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
6455.66\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7168.82\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11047\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
803\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
importin alpha-4 subunit (karyopherin alpha-4 subunit) (qip1 protein). [source:swissprot;acc:o00629]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
6455.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7167.96\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11045\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7837.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
8162.73\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.04143\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
804\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase b22 subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-b22) (ci-b22). [source:swissprot;acc:q9y6m9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6770.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
7517.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.11036\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/